Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By



This article was originally published in The Tan Sheet

Executive Summary

Founder and Chairman Sam Caster unanimously appointed CEO by the Board of Directors April 15. He succeeds CEO and Board Member Robert Henry, who will continue to work with the firm as a consultant during the transition...

You may also be interested in...

Business/Finance In Brief

Twinlab: Discontinuation of ephedra sales accounted for 17.1% drop in Q1 revenue to $37.7 mil., Twinlab says in May 15 1earnings release. Hauppauge, N.Y.-based firm recorded net loss of $3.7 mil. in first quarter, compared to net income of $3.7 mil. in Q1 2002. Loss includes "restructuring charges of $1 mil. relating to the facilities consolidation and a gain on the sale of the assets of Bronson Labs" of $800,000. Firm points out net income in Q1 2002 included federal income tax benefit of $6.9 mil. Twinlab has classified its mortgage agreement for Utah facility, borrowings under revolving credit facility as "current liabilities" and is working to amend mortgage agreement, find alternatives to RCF...

Biogen’s Recipe For Success In Knowledge Management

Biogen’s “recipe-driven qualification” knowledge management program standardizes data collection and reporting in the laboratory, with efficiency gains of 66%.

Market Intel: Minimally Invasive Procedures Gaining Traction In BPH Treatment Market

Less-invasive technologies to treat benign prostatic hyperplasia are fast becoming viable alternatives to medication and surgery. Landmark studies of newer techniques have led the American Urological Association to update its guidelines.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts